Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality.

Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality. Curr Vasc Pharmacol. 2018;16(3):206-208 Authors: Athyros VG, Doumas M PMID: 29598814 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29598814?dopt=Abstract

Source: Current Vascular Pharmacology - April 1, 2018 Category: Drugs & Pharmacology Authors: Athyros VG, Doumas M Tags: Curr Vasc Pharmacol Source Type: research